Dec. 4, 2003 — Molecular Imprints Inc., an Austin, Texas, developer of imprint lithography systems, has made an initial close on $15 million of an ongoing $30 million Series B funding round, according to a company spokeswoman.
New investor Carl Zeiss SMT AG is the lead investor. Hakuto Co. Ltd. also participated. As part of the deal, Zeiss will be the exclusive distributor of the company’s Imprio imprint lithography equipment in Europe and Hakuto will be exclusive distributor in Japan. Previous investors also participated in the funding.
The company anticipates closing on an additional $15 million in the next few weeks. The funds will be used to expand operations, hire additional staff and expand office and research space.